Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Bluelinea
  6. News
  7. Summary
    ALBLU   FR0011041011

BLUELINEA

(ALBLU)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Bluelinea Société Anonyme announced that it has received €4.5 million in funding from Hager SE, Swen Capital Partners, SA, Amundi Private Equity Funds, NextStage AM

06/28/2016 EDT

On June 28, 2016, Bluelinea Société Anonyme (ENXTPA:ALBLU) closed the transaction. The company issued 600,000 shares for gross proceeds of €4,500,000. The company also issued 600,000 warrants. APICIL and the investment funds of Amundi Private Equity Funds, NextStage AM and Swen Capital Partners, SA participated and purchased 200,000 shares and were allotted 200,000 warrants. The capital of the company will be divided into 3,395,104 shares. The company is owned at 21.4% by its founders and its management, 27.6% by investment firms, 19.2% by strategic partners and 31.8% by other shareholders.


© S&P Capital IQ 2016
All news about BLUELINEA
07/06GLOBAL MARKETS LIVE : Facebook, AngloGold, Didi, Weibo, Daimler...
06/16GLOBAL MARKETS LIVE : Oracle, General Motors, Credit Suisse, Sony, Made.com...
2020Bluelinea Société Anonyme acquired 25% stake in Les Autonomie Planners.
CI
2018Bluelinea Société Anonyme announced that it expects to receive €2.055549 mill..
CI
2017Bluelinea Société Anonyme acquired , Direct Sales Activity from Fondation San..
CI
2016BLUELINEA : partners in Horizon 2020 STARR project on self-management and preven..
PU
2016Bluelinea Société Anonyme announced that it has received €4.5 million in fund..
CI
2016Bluelinea Société Anonyme announced that it expects to receive €3 million in ..
CI
More news
Financials
Sales 2020 7,25 M 8,50 M 8,50 M
Net income 2020 -2,70 M -3,17 M -3,17 M
Net Debt 2020 2,45 M 2,87 M 2,87 M
P/E ratio 2020 -7,80x
Yield 2020 -
Capitalization 19,5 M 22,9 M 22,8 M
EV / Sales 2019 2,83x
EV / Sales 2020 3,25x
Nbr of Employees 77
Free-Float 64,0%
Chart BLUELINEA
Duration : Period :
Bluelinea Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BLUELINEA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 4,69 €
Average target price 8,80 €
Spread / Average Target 87,6%
Managers and Directors
Laurent Levasseur Chairman-Management Board
Eric Gbianza Chief Financial Officer
Alexis Westermann Chairman-Supervisory Board
Sandrine Degos Independent Member-Supervisory Board
Eric Bodilsen Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BLUELINEA-7.68%23
ABBOTT LABORATORIES16.39%225 928
MEDTRONIC PLC11.76%176 193
BECTON, DICKINSON AND COMPANY4.98%75 436
HOYA CORPORATION30.10%63 907
ALIGN TECHNOLOGY, INC.36.29%57 543